Table: Torii Pharmaceutical - Q1 parent results
Apr 25 (Reuters)-
Torii Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Mar 31, 2019 Mar 31, 2018 Dec 31, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 9.16 13.93 38.00
(-34.2 pct) (+2.4 pct) (-39.2 pct)
Operating loss 709 mln 769 mln loss 3.20
(+44.2 pct)
Recurring loss 656 mln 790 mln loss 3.10
(+42.2 pct)
Net 28.52 569 mln 22.50
(+46.4 pct)
EPS 1,016.43 yen 20.29 yen 801.82 yen
EPS Diluted 20.29 yen
Ann Div 48.00 yen 48.00 yen
-Q2 div 24.00 yen 24.00 yen
-Q4 div 24.00 yen 24.00 yen
NOTE - Torii Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)